AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $705,889 | -82.1% | 10,100 | -81.6% | 0.01% | -84.3% |
Q2 2023 | $3,952,300 | +6.8% | 55,000 | -8.3% | 0.07% | -2.8% |
Q1 2023 | $3,700,800 | -35.7% | 60,000 | -19.6% | 0.07% | -20.0% |
Q4 2022 | $5,753,898 | -30.1% | 74,600 | -65.3% | 0.09% | -21.1% |
Q2 2022 | $8,234,000 | -53.1% | 215,000 | -49.3% | 0.11% | -46.0% |
Q1 2022 | $17,553,000 | +83.6% | 424,000 | +67.6% | 0.21% | +97.2% |
Q4 2021 | $9,558,000 | +19.8% | 253,000 | +4.5% | 0.11% | +17.6% |
Q3 2021 | $7,976,000 | -61.1% | 242,000 | -30.6% | 0.09% | -92.2% |
Q1 2020 | $20,524,000 | +38.5% | 348,900 | +143.3% | 1.16% | +132.9% |
Q4 2019 | $14,820,000 | +161.1% | 143,400 | -48.9% | 0.50% | +68.8% |
Q3 2019 | $5,675,000 | +239.0% | 280,400 | +331.4% | 0.30% | +251.2% |
Q2 2019 | $1,674,000 | +0.1% | 65,000 | -44.7% | 0.08% | -9.7% |
Q1 2019 | $1,672,000 | – | 117,500 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |